clinical trial

Pancreatic cancer treatment ushered in a major breakthrough. The US FDA approved the new drug Rasonque, which nearly doubled the median survival time of patients.

Summary: The U.S. Food and Drug Administration (FDA) on Wednesday approved the marketing application for Revolution Medi